All the stock tips from this week on Switzer Investing TV (11 May 2026)
Switzer Investing TV aired its 13 April 2026 edition with a panel of expert investors. Here's what they're looking at on the market, and all their latest stock tips.
Monday Edition, 11 May 2026
Switzer on Saturday, 9 May 2026
Peace had a good week, but can we bank on it?
The prospects of peace have been a positive fillip for stocks this week with oil prices down from recent highs, though our market did get the nervous 'yips' that golfers suffer when they lose confidence in themselves.
Thursday Edition, 7 May 2026
The Return of the King
Here are four ETF ideas for conservative yield-focused investors as the cash rate rises.
Questions of the Week (7 May 2026)
How should I play the takeover offer for Atlas Arteria? What do the major brokers think of Woodside? Can I sell my entitlements in the BWP capital raising? How do I participate in the NAB Dividend Re-investment Plan, which is issuing shares at a discount?
“HOT” stock: Macquarie Group (MQG)
Michael Gable, Managing Director of Fairmont Equities, shares his view with you on Macquarie Group (MQG).
Boom, Doom, Zoom! live show | 7 May 2026: SpaceX ready for IPO blast-off, Tabcorp troubles and calling time on Telstra
In this week’s Boom Doom Zoom, we get a question on how to get in on the SpaceX IPO, and cover everything from Tabcorp to Telstra.
Monday Edition, 4 May 2026
Health stocks have to eventually make healthier returns
Is it time to relook at the healthcare sector? Here are 5 healthcare stocks that could be on the way up. But if you don't want to 'bet' on one company, possibly an ETF like the well-named DRUG, could be an option.
Portfolios outperform in an underwhelming Australian market
In a month where the US S&P 500 added 10.5%, the Aussie share market clawed higher in April to record a gain of just 2.2%. Our model portfolios, which are marginally overweight resources, continued to outperform.
‘HOT’ stock: ResMed (RMD)
Raymond Chan, Private Adviser & Head of Asian Desk at Morgans, explains why Morgans regards ResMed (RMD) as a BUY.
Three potential IT ‘A-graders’
Here are three stocks, two with world-leading proprietary software and one with a growing specialisation in providing its clients with the capability and capacity to make AI viable for them. Each one looks to have substantial scope to rise from current prices.
Buy, Hold, Sell, What the Brokers Say (4 May 2026)
For the week ending Friday 1 May 2026, FNArena recorded nine upgrades and 10 downgrades from the seven brokers monitored daily across ASX-listed companies.
Our charting expert calls where ASX is headed next, and why the RBA will up rates | 4 May 2026 | New-look Switzer TV – 28 April 2026
On the eve of the RBA's May rate decision, four expert guests joined Peter Switzer to discuss the macro setup, where the charts are pointing, and which stocks are positioned best heading into a potential third rate hike for 2026.
All the stock tips from this week on Switzer Investing TV (4 May 2026)
Switzer TV aired its 4 May 2026 edition on the eve of the RBA's May rate decision, with four expert guests joining Peter Switzer to discuss the macro setup, where the charts are pointing, and which stocks are positioned best heading into a potential third rate hike for 2026.
Switzer on Saturday, 2 May 2026
What’s behind the fall in oil prices and the spike in markets?
Stocks were largely up on Wall Street for Friday's trade, and it followed our local market snapping our worst run of outs — eight days down since 2018. It coincided with a falling oil price despite President Trump standing firm on maintaining the US Navy blockade of Iranian ports.
Thursday Edition, 30 April 2026
Five gold stars on the ASX
Here are five companies that brought out strong reports for the March 2026 quarter; all of which appear to offer good value at current prices.